Bret Vallacher at Massey & Gail LLP is experienced in representing clients on both the defendant and plaintiff side. Vallacher’s clients span a range of industries from financial services to childcare.
Legal 500 Editorial commentary
Phone
202.780.0351
Email

Accolades

Washington DC Elite

Profile

Position

Partner

Career

Bret Vallacher is a commercial litigator who has represented clients on both sides of the “V” in high-stakes cases and appeals. He has defended Fortune 100 companies and the United States Government from civil suits and represented classes of plaintiffs—including shareholders, employees, and consumers—in advancing their claims for relief. His experience spans a wide range of matters, including contract, securities, antitrust, employment, trade secret, trademark, deceptive trade practices, fraud, defamation, election law, and constitutional takings.

Before joining the firm, Bret served as a Trial Attorney in the Commercial Litigation Branch of the United States Department of Justice, where he first-chaired dozens of cases in federal trial and appellate courts involving breach of contract, constitutional takings, employment disputes, bid protests, and international trade. Earlier in his career, Bret clerked for federal trial and appellate judges and practiced at Boies Schiller Flexner LLP and Jones Day.

Bret received his J.D. from Stanford Law School, where he served as a judicial extern to the Navy-Marine Corps Court of Criminal Appeals and worked in the Stanford Criminal Defense Clinic, where he successfully obtained dismissals for all of his clients.

Education
  • Stanford Law School, J.D., pro bono distinction, 2013
  • Dartmouth College, B.A., cum laude, 2010

Content supplied by Massey & Gail LLP

Key clients

  • Configo Health, Inc.
  • Healthcare Distribution Alliance (HDA)

Work highlights

Defended Configo Health, Inc., an analytics startup in a high-stakes trade secret disputes. The National Association of Children’s Hospitals (CHA) alleged that the client misappropriated trade secrets. Key claims were dismissed (which CHA later withdrew) and advanced counterclaims centered on antitrust violations.